TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.21), $0.05 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $21.28 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Equirus Starts JSW Energy Ltd (JSW:IN) at Long (1)
• CORVEX (MOVE) files for 53.39M share offering by selling stockholders
• Prabhudas Lilladher Reiterates Hold (3) Rating on Avenue Supermarts (DMART:IN)